Effect of ALDH1 on prognosis and chemoresistance by breast cancer subtype
Published 2016 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Effect of ALDH1 on prognosis and chemoresistance by breast cancer subtype
Authors
Keywords
Breast cancer, Stem cell, ALDH1, Prognosis, Chemoresistance, Subtype
Journal
BREAST CANCER RESEARCH AND TREATMENT
Volume 156, Issue 2, Pages 261-269
Publisher
Springer Nature
Online
2016-03-18
DOI
10.1007/s10549-016-3738-7
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- ALDH1A1 expression correlates with clinicopathologic features and poor prognosis of breast cancer patients: a systematic review and meta-analysis
- (2014) Ying Liu et al. BMC CANCER
- Clinicopathologic Characteristics of Breast Cancer Stem Cells Identified on the Basis of Aldehyde Dehydrogenase 1 Expression
- (2014) Yoon Seok Kim et al. Journal of Breast Cancer
- HER2 and Breast Cancer Stem Cells: More than Meets the Eye
- (2013) H. Korkaya et al. CANCER RESEARCH
- HER2 Drives Luminal Breast Cancer Stem Cells in the Absence of HER2 Amplification: Implications for Efficacy of Adjuvant Trastuzumab
- (2013) S. Ithimakin et al. CANCER RESEARCH
- Novel prognostic markers for patients with triple-negative breast cancer
- (2013) Ling Zhou et al. HUMAN PATHOLOGY
- Recommendations for Human Epidermal Growth Factor Receptor 2 Testing in Breast Cancer: American Society of Clinical Oncology/College of American Pathologists Clinical Practice Guideline Update
- (2013) Antonio C. Wolff et al. JOURNAL OF CLINICAL ONCOLOGY
- Age determines the prognostic role of the cancer stem cell marker aldehyde dehydrogenase-1 in breast cancer
- (2012) J Sven D Mieog et al. BMC CANCER
- Immunohistochemical Detection of Breast Cancer Stem Cells in Hormone Receptor-Positive Breast Cancer and Their Role in Response to Endocrine Therapy and Clinical Outcome
- (2012) Kenji Hashimoto et al. ONCOLOGY
- Prognostic impact of the cancer stem cell related markers ALDH1 and EZH2 in triple negative and basal-like breast cancers
- (2012) Marina De Brot et al. PATHOLOGY
- Aldehyde dehydrogenase 1 expression predicts poor prognosis in triple-negative breast cancer
- (2011) Yasuyo Ohi et al. HISTOPATHOLOGY
- Aldehyde dehydrogenase 1 expression is a predictor of poor prognosis in node-positive breast cancers: a long-term follow-up study
- (2011) Takako Yoshioka et al. HISTOPATHOLOGY
- Breast cancer stem cell markers CD44, CD24 and ALDH1: expression distribution within intrinsic molecular subtype
- (2011) S. Ricardo et al. JOURNAL OF CLINICAL PATHOLOGY
- Human Neural Stem Cell Tropism to Metastatic Breast Cancer
- (2011) Donghong Zhao et al. STEM CELLS
- In Situ Identification of Putative Cancer Stem Cells by Multiplexing ALDH1, CD44, and Cytokeratin Identifies Breast Cancer Patients with Poor Prognosis
- (2010) Veronique Neumeister et al. AMERICAN JOURNAL OF PATHOLOGY
- The prognostic role of cancer stem cells in breast cancer: a meta-analysis of published literatures
- (2010) Liheng Zhou et al. BREAST CANCER RESEARCH AND TREATMENT
- Prognostic impact of ALDH1 in breast cancer: a story of stem cells and tumor microenvironment
- (2009) Erika Resetkova et al. BREAST CANCER RESEARCH AND TREATMENT
- Stem cell marker aldehyde dehydrogenase 1-positive breast cancers are characterized by negative estrogen receptor, positive human epidermal growth factor receptor type 2, and high Ki67 expression
- (2009) Koji Morimoto et al. CANCER SCIENCE
- Association of Breast Cancer Stem Cells Identified by Aldehyde Dehydrogenase 1 Expression with Resistance to Sequential Paclitaxel and Epirubicin-Based Chemotherapy for Breast Cancers
- (2009) T. Tanei et al. CLINICAL CANCER RESEARCH
- Cancer stem cells: mirage or reality?
- (2009) Piyush B Gupta et al. NATURE MEDICINE
- Implications of the Cancer Stem-Cell Hypothesis for Breast Cancer Prevention and Therapy
- (2008) Madhuri Kakarala et al. JOURNAL OF CLINICAL ONCOLOGY
- Intrinsic Resistance of Tumorigenic Breast Cancer Cells to Chemotherapy
- (2008) X. Li et al. JNCI-Journal of the National Cancer Institute
- HER2Status and Benefit from Adjuvant Trastuzumab in Breast Cancer
- (2008) Soonmyung Paik et al. NEW ENGLAND JOURNAL OF MEDICINE
- HER2 regulates the mammary stem/progenitor cell population driving tumorigenesis and invasion
- (2008) H Korkaya et al. ONCOGENE
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now